## Abstract ^123^I‐iodophenylpentadecanoic acid (IPPA) and ^123^I‐beta‐methyliodophenylpentadecanoic acid (BMIPP) are radiolabelled fatty acid derivatives used for assessment of myocardial viability. Because of limited accessibility of ^123^I in the clinical scenario, a 99m‐technetium‐based agent w
Synthesis and evaluation of potential tumor localizing radiopharmaceuticals: Technetium-99m iminodiacetic acid derivatives of sulfanilamides
✍ Scribed by F. C. Hunt; D. J. Maddalena; A. B. McLaren; J. G. Wilson
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- French
- Weight
- 266 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
To exploit the tissue affinity of compounds for radiopharmaceutical purposes, attachment of chelating groups is usually necessary to facilitate technetium‐99m binding and transport.
The chelating group, iminodiacetic acid, previously used to modify lidocaine for hepatobiliary radiopharmaceuticals, was attached to several antibiotic sulfanilamides known to concentrate in certain transplanted animal tumors.
These iminodiacetic acid derivatives were labelled with technetium‐99m by the stannous chloride reduction method.
Biodistribution of the ^99m^Tc labelled compounds in tumor bearing rats revealed no specific concentration in the tumors and localization mainly in the excretory organs.
The results indicate that, as in the case of lidocaine, conversion of the sulfanilamides into iminodiacetic acid derivatives and chelation with technetium leads to an altered biodistribution and loss of biological specificity.
📜 SIMILAR VOLUMES
## Abstract Determination of hypoxia in tumor is an important problem in the clinical management of cancer. Towards this, a series of differently substituted nitroimidazoles, viz. 2‐nitro, 4‐nitro and 5‐nitroimidazole iminodiacetic acid (IDA) derivatives were synthesized and radio‐labeled with a [^